Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service

BACKGROUND: Single gene tests to predict whether cancers respond to specific targeted therapies are performed increasingly often. Advances in sequencing technology, collectively referred to as next generation sequencing (NGS), mean the entire cancer genome or parts of it can now be sequenced at spee...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamblin, Angela, Wordsworth, Sarah, Fermont, Jilles M., Page, Suzanne, Kaur, Kulvinder, Camps, Carme, Kaisaki, Pamela, Gupta, Avinash, Talbot, Denis, Middleton, Mark, Henderson, Shirley, Cutts, Anthony, Vavoulis, Dimitrios V., Housby, Nick, Tomlinson, Ian, Taylor, Jenny C., Schuh, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308858/
https://www.ncbi.nlm.nih.gov/pubmed/28196074
http://dx.doi.org/10.1371/journal.pmed.1002230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308858/
https://www.ncbi.nlm.nih.gov/pubmed/28196074
http://dx.doi.org/10.1371/journal.pmed.1002230

Ejemplares similares